IN THIS ISSUE

Susan Ladika
Incidence was dipping to all-time lows. Then a perfect storm hit, and the cost is $16 billion a year.
Q&A
Interview by Peter Wehrwein
Journalist David France’s How to Survive a Plague is a searing firsthand account of the early years of the HIV/AIDS epidemic in New York City. AIDS activists, most of them gay men, were fighting for their lives. Researchers, politicians, public health officials, and pharma were slow to respond—or resisted outright.
Original Research
Jennifer Jones, MD, FRCPC
Mark Borgaonkar, MD, MSc, FRCPC
Jesse Siffledeen, MD, MSc, FRCPC
Legislation & Regulation
Richard Mark Kirkner
Use of long-acting, reversible contraceptives dipped while Medicaid-covered births went up when Texas stopped state funding of Planned Parenthood.
Viewpoint
Zachary Hafner
Why is care for sexual health issues considered a luxury when it’s a necessary part of population health?
Tomorrow's Medicine
Thomas Morrow, MD

Thomas Morrow, MD

Spinraza is a breakthrough, no doubt. But it is another ultraexpensive drug, and the evidence so far points to a modest improvement in motor milestones.
News & Commentary
Frank Diamond